发明名称 5-fluoro-3-phenyl-2[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta
摘要 Compounds that inhibit PI3Kδ activity, including compounds that selectively inhibit PI3Kδ activity, are disclosed. Methods of inhibiting phosphatidylinositol 3-kinase delta isoform (PI3Kδ) activity, and methods of treating diseases, such as disorders of immunity and inflammation in which PI3Kδ plays a role in leukocyte function, using the compounds also are disclosed. Exemplary compounds disclosed in this application are shown below:;
申请公布号 US8980901(B2) 申请公布日期 2015.03.17
申请号 US201314049163 申请日期 2013.10.08
申请人 Icos Corporation 发明人 Fowler Kerry W.;Huang Danwen;Kesicki Edward A.;Ooi Hua Chee;Oliver Amy;Ruan Fuqiang;Treiberg Jennifer;Puri Kamal Deep
分类号 A61K31/517;C07D239/91;A61K31/52;C07D473/16;C07D473/34;C07D487/04 主分类号 A61K31/517
代理机构 Morrison & Foerster LLP 代理人 Morrison & Foerster LLP
主权项 1. A method of treating a hematological malignancy in a human, comprising administering to the human a compound selected from the group consisting of or a pharmaceutically acceptable salt thereof.
地址 Foster City CA US